Jason Walsh, MD
Surgery · Kearney, NENPI 1518971282
Payments from drug & device makers
What this record shows
This record is dominated by education: $45,000 of the $57,771 with a category attached, or 77.9%. Intuitive Surgical accounts for 93.1% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $19,470 and has fallen 82.2% since, to $3,471 in 2025. Among surgery clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 146 payments — averaging $395.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$54K
- BD$1K
- Davol Inc.$985
- Medical Device Business Services, Inc.$639
- Johnson & Johnson$253
- AbbVie$125
- plus $667 from 20 others
What the payments were for
- Travel & lodging$7,55213%
- Food & beverage$4,4768%
- Education$45,00078%
- Gifts$7431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 92 | $53,782 |
| BD | 3 | $1,319 |
| Davol Inc. | 6 | $985 |
| Medical Device Business Services, Inc. | 2 | $639 |
| Johnson & Johnson(2 entities) | 9 | $253 |
| AbbVie | 5 | $125 |
| Stryker | 2 | $96 |
| Kls-martin L.p. | 1 | $88 |
| Kerecis Limited | 2 | $74 |
| Medtronic(2 entities) | 3 | $69 |
| Pfizer | 3 | $47 |
| Integra Lifesciences Corporation | 2 | $46 |
| Organogenesis Inc. | 2 | $27 |
| Novo Nordisk | 2 | $27 |
| Smith+Nephew | 1 | $26 |
| Linvatec Corporation | 1 | $23 |
| KCI USA, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Biogen | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Medline Industries LP | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Covidien LP | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$51,610
- Phasix Mesh$2,156
- SYNFIX$639
How this compares
$57,771 in reported general payments places this provider in the 95th percentile of 197 surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErtapenemErtapenem Sodium | 13 | $8,065 |
| Pantoprazole Sodium | 21 | $137 |
Paid to pharmacies, not to this prescriber.
Other surgery in Kearney
- Brittney Maloley-LewisKearney$9K
- Melissa StadeKearney$3K
- Dmitry OleynikovOmaha$180K
- Benjamin HungLincoln$75K
- Gary AnthoneOmaha$71K
- Moriah WrightOmaha$37K
- Andy YangOmaha$36K
- Matthew WheelerBellevue$32K
- Brad WintersteinOmaha$30K
- Ali KhiabaniOmaha$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.